LABORATOIRES PHARMACEUTIQUES RODAEL : revenue, balance sheet and financial ratios

LABORATOIRES PHARMACEUTIQUES RODAEL is a French company founded 28 years ago, specialized in the sector Fabrication de préparations pharmaceutiques. Based in BIERNE (59380), this company of category ETI shows in 2019 a revenue of 6.5 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - LABORATOIRES PHARMACEUTIQUES RODAEL (SIREN 414952127)
Indicator 2023 2019 2018 2017
Revenue N/C 6 494 991 € 6 651 960 € 6 948 659 €
Net income -312 150 € -157 780 € 87 674 € -199 490 €
EBITDA N/C 31 888 € 210 630 € 2 519 554 €
Net margin N/C -2.4% 1.3% -2.9%

Revenue and income statement

In 2023, LABORATOIRES PHARMACEUTIQUES RODAEL records a net loss of 312 k€. This deficit will reduce equity on the balance sheet.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-312 150 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 125%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 23%. The balance between equity and debt is satisfactory.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

125.262%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

22.899%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

17.2%

Solvency indicators evolution
LABORATOIRES PHARMACEUTIQUES RODAEL

Sector positioning

Debt ratio
125.26 2023
2018
2019
2023
Q1: 0.0
Med: 2.28
Q3: 51.98
Watch +24 pts over 3 years

In 2023, the debt ratio of LABORATOIRES PHARMACEUTIQ... (125.26) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
22.9% 2023
2018
2019
2023
Q1: 25.54%
Med: 52.2%
Q3: 68.87%
Watch -51 pts over 3 years

In 2023, the financial autonomy of LABORATOIRES PHARMACEUTIQ... (22.9%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Repayment capacity
23.27 years 2019
2018
2019
Q1: 0.0 years
Med: 0.0 years
Q3: 1.18 years
Watch +8 pts over 2 years

In 2019, the repayment capacity of LABORATOIRES PHARMACEUTIQ... (23.27) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 156.20. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

156.204

Liquidity indicators evolution
LABORATOIRES PHARMACEUTIQUES RODAEL

Sector positioning

Liquidity ratio
156.2 2023
2018
2019
2023
Q1: 112.83
Med: 200.61
Q3: 363.19
Average -38 pts over 3 years

In 2023, the liquidity ratio of LABORATOIRES PHARMACEUTIQ... (156.20) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
12.92x 2019
2018
2019
Q1: 0.0x
Med: 0.41x
Q3: 3.69x
Excellent +23 pts over 2 years

In 2019, the interest coverage of LABORATOIRES PHARMACEUTIQ... (12.9x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2023) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2023) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2023) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2023) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
LABORATOIRES PHARMACEUTIQUES RODAEL

Positioning of LABORATOIRES PHARMACEUTIQUES RODAEL in its sector

Comparison with sector Fabrication de préparations pharmaceutiques

Similar companies (Fabrication de préparations pharmaceutiques)

Compare LABORATOIRES PHARMACEUTIQUES RODAEL with other companies in the same sector:

Voir toutes les statistiques du secteur Fabrication de préparations pharmaceutiques

Frequently asked questions about LABORATOIRES PHARMACEUTIQUES RODAEL

What is the revenue of LABORATOIRES PHARMACEUTIQUES RODAEL ?

The revenue of LABORATOIRES PHARMACEUTIQUES RODAEL in 2019 is 6.5 M€.

Is LABORATOIRES PHARMACEUTIQUES RODAEL profitable?

LABORATOIRES PHARMACEUTIQUES RODAEL recorded a net loss in 2023.

Where is the headquarters of LABORATOIRES PHARMACEUTIQUES RODAEL ?

The headquarters of LABORATOIRES PHARMACEUTIQUES RODAEL is located in BIERNE (59380), in the department Nord.

Where to find the tax return of LABORATOIRES PHARMACEUTIQUES RODAEL ?

The tax return of LABORATOIRES PHARMACEUTIQUES RODAEL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does LABORATOIRES PHARMACEUTIQUES RODAEL operate?

LABORATOIRES PHARMACEUTIQUES RODAEL operates in the sector Fabrication de préparations pharmaceutiques (NAF code 21.20Z). See the 'Sector positioning' section above to compare the company with its competitors.